Want to see IN:AJOONI full AI Analyst Report?
Ajooni Biotech Limited (AJOONI) Ratios
Ajooni Biotech Limited Ratios
IN:AJOONI's free cash flow for Q1 2027 was $0.00. For the 2027 fiscal year, IN:AJOONI's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.72 | 12.86 | 10.74 | 2.28 | 2.18 |
| Quick Ratio | 1.28 | 7.89 | 5.63 | 1.82 | 1.60 |
| Cash Ratio | 0.02 | 1.42 | 0.14 | 0.02 | 0.01 |
| Solvency Ratio | 0.22 | 0.62 | 0.63 | 0.12 | 0.17 |
| Operating Cash Flow Ratio | -0.19 | -3.56 | -1.31 | -0.37 | 0.37 |
| Short-Term Operating Cash Flow Coverage | -0.32 | 0.00 | -8.14 | -1.63 | 1.33 |
| Net Current Asset Value | $ 453.03M | $ 550.32M | $ 275.17M | $ 176.09M | $ 92.91M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.15 | 0.02 | 0.05 | 0.09 | 0.18 |
| Debt-to-Equity Ratio | 0.19 | 0.02 | 0.05 | 0.12 | 0.33 |
| Debt-to-Capital Ratio | 0.16 | 0.02 | 0.05 | 0.11 | 0.25 |
| Long-Term Debt-to-Capital Ratio | 0.02 | 0.02 | 0.04 | 0.04 | 0.14 |
| Financial Leverage Ratio | 1.32 | 1.08 | 1.11 | 1.41 | 1.77 |
| Debt Service Coverage Ratio | 0.29 | 13.96 | 3.45 | 0.67 | 0.81 |
| Interest Coverage Ratio | 5.55 | 7.76 | 2.72 | 3.69 | 3.66 |
| Debt to Market Cap | 0.10 | 0.02 | 0.04 | 0.32 | 0.09 |
| Interest Debt Per Share | 0.39 | 0.12 | 0.27 | 1.22 | 1.04 |
| Net Debt to EBITDA | 2.77 | -0.85 | 0.39 | 1.59 | 1.70 |
| Profitability Margins | |||||
| Gross Profit Margin | 15.17% | 12.04% | 12.19% | 11.74% | 13.54% |
| EBIT Margin | 2.22% | 4.07% | 4.42% | 2.75% | 2.70% |
| EBITDA Margin | 3.43% | 5.02% | 5.53% | 4.11% | 4.20% |
| Operating Profit Margin | 2.22% | 2.26% | 1.89% | 2.37% | 2.67% |
| Pretax Profit Margin | 3.15% | 3.77% | 3.74% | 2.12% | 1.97% |
| Net Profit Margin | 2.37% | 2.82% | 2.70% | 1.51% | 1.42% |
| Continuous Operations Profit Margin | 2.37% | 2.94% | 2.70% | 1.51% | 1.42% |
| Net Income Per EBT | 75.32% | 74.79% | 72.13% | 71.33% | 71.78% |
| EBT Per EBIT | 141.70% | 166.85% | 198.04% | 89.41% | 73.98% |
| Return on Assets (ROA) | 3.59% | 3.41% | 4.55% | 1.91% | 3.61% |
| Return on Equity (ROE) | 4.74% | 3.68% | 5.06% | 2.70% | 6.40% |
| Return on Capital Employed (ROCE) | 4.35% | 2.88% | 3.40% | 4.05% | 10.42% |
| Return on Invested Capital (ROIC) | 2.79% | 2.15% | 2.43% | 2.68% | 6.52% |
| Return on Tangible Assets | 3.60% | 3.42% | 4.55% | 2.41% | 4.74% |
| Earnings Yield | 2.34% | 2.92% | 4.01% | 6.98% | 1.77% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.70 | 3.88 | 6.18 | 3.61 | 5.35 |
| Payables Turnover | 17.36 | 28.86 | 44.40 | 6.50 | 9.41 |
| Inventory Turnover | 3.92 | 4.21 | 4.58 | 9.40 | 10.88 |
| Fixed Asset Turnover | 7.05 | 10.22 | 7.13 | 11.37 | 11.93 |
| Asset Turnover | 1.52 | 1.21 | 1.69 | 1.27 | 2.55 |
| Working Capital Turnover Ratio | 3.50 | 2.65 | 3.28 | 4.76 | 6.49 |
| Cash Conversion Cycle | 136.07 | 168.10 | 130.55 | 83.70 | 63.00 |
| Days of Sales Outstanding | 64.01 | 93.95 | 59.04 | 101.00 | 68.23 |
| Days of Inventory Outstanding | 93.09 | 86.79 | 79.73 | 38.83 | 33.54 |
| Days of Payables Outstanding | 21.03 | 12.65 | 8.22 | 56.14 | 38.77 |
| Operating Cycle | 157.10 | 180.74 | 138.77 | 139.83 | 101.77 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.11 | -0.94 | -0.40 | -1.21 | 0.65 |
| Free Cash Flow Per Share | -0.48 | -1.05 | -0.96 | -1.82 | 0.27 |
| Dividend Paid and CapEx Coverage Ratio | -0.29 | -8.45 | -0.71 | -1.95 | 1.73 |
| Capital Expenditure Coverage Ratio | -0.29 | -8.45 | -0.71 | -1.95 | 1.73 |
| Operating Cash Flow Coverage Ratio | -0.29 | -8.86 | -1.82 | -1.08 | 0.69 |
| Operating Cash Flow to Sales Ratio | -0.03 | -0.15 | -0.05 | -0.07 | 0.05 |
| Free Cash Flow Yield | -12.60% | -17.31% | -17.74% | -52.41% | 2.63% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 42.67 | 33.78 | 24.92 | 14.32 | 56.58 |
| Price-to-Sales (P/S) Ratio | 1.01 | 0.97 | 0.67 | 0.22 | 0.80 |
| Price-to-Book (P/B) Ratio | 2.02 | 1.26 | 1.26 | 0.39 | 3.62 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -7.94 | -5.78 | -5.64 | -1.91 | 38.05 |
| Price-to-Operating Cash Flow Ratio | -35.44 | -6.46 | -13.63 | -2.89 | 16.11 |
| Price-to-Earnings Growth (PEG) Ratio | -0.85 | -1.86 | -2.99 | 0.43 | 0.33 |
| Enterprise Value Multiple | 32.25 | 18.43 | 12.56 | 6.85 | 20.77 |
| Enterprise Value | 2.02B | 1.06B | 555.99M | 209.71M | 646.38M |
| EV to EBITDA | 32.25 | 18.43 | 12.56 | 6.85 | 20.77 |
| EV to Sales | 1.11 | 0.93 | 0.69 | 0.28 | 0.87 |
| EV to Free Cash Flow | -8.68 | -5.52 | -5.82 | -2.48 | 41.44 |
| EV to Operating Cash Flow | -38.77 | -6.17 | -14.07 | -3.76 | 17.55 |
| Tangible Book Value Per Share | 1.89 | 4.80 | 4.30 | 6.41 | 1.67 |
| Shareholders’ Equity Per Share | 1.90 | 4.82 | 4.30 | 9.01 | 2.89 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.25 | 0.25 | 0.28 | 0.29 | 0.28 |
| Revenue Per Share | 3.80 | 6.28 | 8.06 | 16.10 | 13.05 |
| Net Income Per Share | 0.09 | 0.18 | 0.22 | 0.24 | 0.18 |
| Tax Burden | 0.75 | 0.75 | 0.72 | 0.71 | 0.72 |
| Interest Burden | 1.42 | 0.93 | 0.85 | 0.77 | 0.73 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.13 | 0.10 | 0.01 | 0.01 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -1.20 | -5.31 | -1.83 | -3.54 | 2.52 |
Currency in INR